OTX015 (MK-8628), a novel BET inhibitor, displaysin vitroandin vivoantitumor effects alone and in combination with conventional therapies in glioblastoma models-Reference-Cited by-同舟云学术

OTX015 (MK-8628), a novel BET inhibitor, displaysin vitroandin vivoantitumor effects alone and in combination with conventional therapies in glioblastoma models

Published:2016-07-30 Issue:9 Volume:139 Page:2047-2055
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Berenguer-Daizé Caroline¹,Astorgues-Xerri Lucile²,Odore Elodie²³,Cayol Mylène¹,Cvitkovic Esteban²⁴,Noel Kay⁴,Bekradda Mohamed²,MacKenzie Sarah²,Rezai Keyvan³,Lokiec François³,Riveiro Maria E.²,Ouafik L'Houcine¹

Affiliation:

1. Aix-Marseille Université, Inserm, CRO2 UMR_S 911; Marseille 13385 France

2. Oncology Therapeutic Development; 100 Rue Martre Clichy 92110 France

3. Department of Radio-Pharmacology; Institut Curie, René Huguenin Hospital; 35 Rue Daily Saint-Cloud 92210 France

4. Oncoethix SA (Now Oncoethix GmbH, a Wholly Owned Subsidiary of Merck Sharp and Dohme Corp.); Weystrasse 20 Lucerne 6000 Switzerland

Funder

SIRIC

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Glioblastoma multiforme-an overview;Urbañska;Contemp Oncol (Pozn),2014

2. Pathology of gliomas and developments in molecular testing;Collins;Clin Oncol (R Coll Radiol),2014

3. Advances and challenges in the molecular biology and treatment of glioblastoma-Is there any hope for the future?;Veliz;Ann Transl Med,2015

4. Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of surveillance, epidemiology, and end results registries;Darefsky;Cancer,2012

5. A randomized trial of bevacizumab for newly diagnosed glioblastoma;Gilbert;N Engl J Med,2014

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine;Cell Death Discovery;2024-01-15

2. Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks;Journal of Experimental & Clinical Cancer Research;2024-01-05

3. OTX015 PROTACs: Emerging Novel Therapeutic Agents in Cancer Treatment;BIO Web of Conferences;2024

4. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress;Signal Transduction and Targeted Therapy;2023-10-20

5. Targeting bromodomain-containing proteins: research advances of drug discovery;Molecular Biomedicine;2023-05-05